Author: Youth Medical Journal
-
Submissions Re-opened & Editorial & Publishing Policies Released
Our editorial and publishing policies have finally been released, which also means we have re-opened submissions. Please read the policies before submitting your manuscript. They can be found here. Afterwards, you can read more on how to submit here. This post will be deleted upon the release of the next manuscript.
-
The Evolution of Sulfonylureas as Hypoglycaemic Drugs Over Time, Their Mechanisms and how they Treat Symptoms of Type II Diabetes Mellitus.
This article will explain the chemistry of sulfonylureas, the pharmacology behind them and how they have changed over time to make them more effective in the treatment of type 2 diabetes mellitus.
-
Ageing, genetics and Parkinson’s
Nowadays vast amounts of misinformation surface the internet, constructing controversies. Within the same spectrum, healthcare professionals seek to support or contradict the argument, through evidence-based judgement. Likewise, contributing factors of Parkinson’s disease stand firm ground between the evaluation of healthcare professionals across the platform. The Parkison’s debate, distinctly separates itself into three categories, which will…
-
Dostarlimab: Hope or Hype?
One recent form of immunotherapy, a drug called Dostarlimab, has taken the medical world by storm after a small study reported a 100% complete clinical response.
-
ADHD: Over Diagnosed or Loosely Defined?
Accusations of ADHD’s overdiagnosis have been on a rise in recent years, as have diagnosed cases of ADHD. In 1997, the parent-reported percent of children with an ADHD diagnosis in a National Health Institute survey was just under 6%. Ten years later, this figure had risen to 10% [2].
Youth Medical Journal 